Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

6825 ARTÍCULOS , VIENDO DEL 3076 AL 3090

Aggressive Behaviors in Alzheimer Disease and Mild Cognitive Impairment: Systematic Review and Meta-Analysis

Yu R, Topiwala A, Jacoby R, Fazel S.

Am J Geriatr Psychiatry. 2019 Mar;27(3):290-300. doi: 10.1016/j.jagp.2018.10.008. Epub 2018 Oct 19.

Tau PET Imaging for Staging of Alzheimer's Disease in Down Syndrome

Rafii MS.

Dev Neurobiol. 2019 Jul;79(7):711-715. doi: 10.1002/dneu.22658. Epub 2018 Dec 16.

Supporting breast cancer screening decisions for caregivers of older women with dementia: study protocol for a randomized controlled trial

Fowler NR, Schonberg MA, Sachs GA, Schwartz PH, Gao S, Lane KA, Inger L, Torke AM.

Trials. 2018 Dec 12;19(1):678. doi: 10.1186/s13063-018-3039-z.

Prognosis of conversion of mild cognitive impairment to Alzheimer's dementia by voxel-wise Cox regression based on FDG PET data

Sörensen A, Blazhenets G, Rücker G, Schiller F, Meyer PT, Frings L; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage Clin. 2019;21:101637. doi: 10.1016/j.nicl.2018.101637. Epub 2018 Dec 10.

Olfactory function in mild cognitive impairment and Alzheimer's disease: A meta-analysis

Jung HJ, Shin IS, Lee JE.

Laryngoscope. 2019 Feb;129(2):362-369. doi: 10.1002/lary.27399. Epub 2018 Nov 22.

A survey on applications and analysis methods of functional magnetic resonance imaging for Alzheimer's disease

Forouzannezhad P, Abbaspour A, Fang C, Cabrerizo M, Loewenstein D, Duara R, Adjouadi M.

J Neurosci Methods. 2019 Apr 1;317:121-140. doi: 10.1016/j.jneumeth.2018.12.012. Epub 2018 Dec 26.

Seizure in Alzheimer's Disease: An Underestimated Phenomenon

Asadollahi M, Atazadeh M, Noroozian M.

Am J Alzheimers Dis Other Demen. 2019 Mar;34(2):81-88. doi: 10.1177/1533317518813551. Epub 2018 Dec 30.

Associations of acetylcholinesterase inhibitor treatment with reduced mortality in Alzheimer's disease: a retrospective survival analysis

Mueller C, Perera G, Hayes RD, Shetty H, Stewart R.

Age Ageing. 2018 Jan 1;47(1):88-94. doi: 10.1093/ageing/afx098.

Nanotechnology in Personalized Medicine: A Promising Tool for Alzheimer's Disease Treatment

De Matteis L, Martín-Rapún R, de la Fuente JM.

Curr Med Chem. 2018;25(35):4602-4615. doi: 10.2174/0929867324666171012112026.

Cognitive Training in Patients with Alzheimer's Disease: Findings of a 12-month Randomized Controlled Trial

Trebbastoni A, Imbriano L, Podda L, Rendace L, Sacchetti ML, Campanelli A, D'Antonio F, de Lena C.

Curr Alzheimer Res. 2018 Mar 14;15(5):452-461. doi: 10.2174/1567205014666171113105044.

Potential of Low Dose Leuco-Methylthioninium Bis(Hydromethanesulphonate) (LMTM) Monotherapy for Treatment of Mild Alzheimer's Disease: Cohort Analysis as Modified Primary Outcome in a Phase III Clinical Trial

Wilcock GK, Gauthier S, Frisoni GB, Jia J, Hardlund JH, Moebius HJ, Bentham P, Kook KA, Schelter BO, Wischik DJ, Davis CS, Staff RT, Vuksanovic V, Ahearn T, Bracoud L, Shamsi K, Marek K, Seibyl J, Riedel G, Storey JMD, Harrington CR, Wischik CM.

J Alzheimers Dis. 2018;61(1):435-457. doi: 10.3233/JAD-170560.

Effects of Physical Exercise on Alzheimer's Disease Biomarkers: A Systematic Review of Intervention Studies

Frederiksen KS, Gjerum L, Waldemar G, Hasselbalch SG.

J Alzheimers Dis. 2018;61(1):359-372. doi: 10.3233/JAD-170567.

The Rationale and Design of the Reducing Pathology in Alzheimer's Disease through Angiotensin TaRgeting (RADAR) Trial

Kehoe PG, Blair PS, Howden B, Thomas DL, Malone IB, Horwood J, Clement C, Selman LE, Baber H, Lane A, Coulthard E, Passmore AP, Fox NC, Wilkinson IB, Ben-Shlomo Y.

J Alzheimers Dis. 2018;61(2):803-814. doi: 10.3233/JAD-170101.

[Alzheimer's disease - State of the art, and emerging diagnostics and therapeutics]

Winkler D, Leyhe T.

Ther Umsch. 2018;75(7):432-437. doi: 10.1024/0040-5930/a001020.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias